American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 908-917, December 2007

Changing the Timing of Antihypertensive Therapy to Reduce Nocturnal Blood Pressure in CKD: An 8-Week Uncontrolled Trial

  • Roberto Minutolo, MD, PhD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
    • Corresponding Author InformationAddress correspondence to Roberto Minutolo, MD, PhD, Department of Nephrology, Second University of Naples, Via Tiberio 90 I-80125, Naples, Italy.
  • ,
  • Francis B. Gabbai, MD

      Affiliations

    • Department of Nephrology, University of California at San Diego Medical School, San Diego, CA.
  • ,
  • Silvio Borrelli, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Raffaele Scigliano, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Paolo Trucillo, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Diego Baldanza, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Simona Laurino, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Sara Mascia, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Giuseppe Conte, MD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy
  • ,
  • Luca De Nicola, MD, PhD

      Affiliations

    • Department of Nephrology, Second University of Naples, Naples, Italy

Received 9 May 2007; accepted 18 July 2007. published online 21 September 2007.

Background

Nondipping status is associated with greater cardiovascular morbidity and mortality and faster progression of chronic kidney disease (CKD). We examined whether shifting 1 antihypertensive drug from morning to evening restores the circadian rhythm of blood pressure in nondipper patients with CKD.

Study Design

8-week clinical trial without a control group.

Setting & Participants

We selected from our outpatient renal clinic 32 patients with CKD with estimated glomerular filtration rate less than 90 mL/min/1.73 m2 and night-day ratio of mean ambulatory blood pressure (ABP) greater than 0.9, but with normal daytime ABP (<135/85 mm Hg) to avoid the required therapy intensification.

Intervention

Shifting 1 antihypertensive drug from morning to evening.

Outcomes

Percentage of patients changing the night-day ratio of mean ABP from greater than 0.9 to 0.9 or less 8 weeks after the shift.

Measurements

Office blood pressure/ABP and proteinuria at baseline and after the shift.

Results

There were 55% men with a mean age of 67.4 ± 11.3 years and estimated glomerular filtration rate of 46 ± 12 mL/min/1.73 m2. They were treated with 2.4 ± 1.4 antihypertensive drugs. After the drug shift, the night-day ratio of mean ABP decreased in 93.7% of patients, with normal circadian rhythm restored in 87.5%. The nocturnal systolic and diastolic ABP decrease was not associated with an increase in diurnal ABP and was independent from number and class of shifted drug. Office blood pressure in the morning also decreased (from 136 ± 16/77 ± 10 to 131 ± 13/75 ± 8 mm Hg; P = 0.02). Urinary protein excretion decreased from 235 ± 259 to 167 ± 206 mg/d (P < 0.001).

Limitations

Absence of a control group and patients with severe proteinuria or uncontrolled daytime ABP.

Conclusions

In nondipper patients with CKD, changing the timing of antihypertensive therapy decreases nocturnal blood pressure and proteinuria.

Index Words: Ambulatory blood pressure monitoring, chronic kidney disease, circadian rhythm, chronotherapy, nondipper status

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2007.07.020 on September 21, 2007.

PII: S0272-6386(07)01127-4

doi:10.1053/j.ajkd.2007.07.020

Refers to article:

  • Should Reducing Nocturnal Blood Pressure Be a Therapeutic Target in CKD? The Time Is Ripe for a Clinical Outcomes Trial

    Mahboob Rahman, Lawrence J. Appel
    American Journal of Kidney Diseases December 2007 (Vol. 50, Issue 6, Pages 901-903)

American Journal of Kidney Diseases
Volume 50, Issue 6 , Pages 908-917, December 2007